2. Gene
  3. Cdk9 - cyclin-dependent kinase 9 Gene

Cdk9 - cyclin-dependent kinase 9 Gene

  • 基因
  • 蛋白
  • 相关产品
  • 直系同源

中文名称：细胞周期蛋白依赖性激酶 9

种属: Rattus norvegicus

基因 ID: 362110 | 基因类型: protein coding

关于 Cdk9

Biased expression in Spleen (RPKM 124.8), Thymus (RPKM 121.4) and 9 other tissues.

功能概要

该基因编码的蛋白可启动染色质结合活性。参与心肌肥大的正调节和对外源刺激的反应。位于核内。与人 CDK9（细胞周期蛋白依赖性激酶 9）同源。 [由基因组资源联盟提供，2022 年 4 月]

Enables chromatin binding activity. Involved in positive regulation of cardiac muscle hypertrophy and response to xenobiotic stimulus. Located in nucleus. Orthologous to human CDK9 (cyclin dependent kinase 9). [provided by Alliance of Genome Resources, Apr 2022]

Cdk9 基因产物(1)

mRNA Protein Name
NM_001007743.1 NP_001007744.1 cyclin-dependent kinase 9

Cdk9 蛋白结构

STKc_CDK9

STKc_CDK9: cd07865 (5 - 314)

  • 0
  • 100
  • 200
  • 300
  • 372 a.a.
蛋白主名 其他名称

cyclin-dependent kinase 9

cell division protein kinase 9

cyclin-dependent kinase 9 (CDC2-related kinase)

相关产品

Approval
生物活性分子 (3)
目录号 产品名 作用方式
纯度 是否罕见病
HY-16297A Abemaciclib Inhibitor 99.96% 是
HY-10492 Dinaciclib Inhibitor 99.44% 是
HY-16297 Abemaciclib methanesulfonate Inhibitor 99.95% 是
Clinical Phase
生物活性分子 (22)
目录号 产品名 作用方式
纯度 Phase
HY-112088 AZD4573 Inhibitor 99.97% Phase 2
HY-101212 Fadraciclib Inhibitor 99.78% Phase 2
HY-50940 AT7519 Inhibitor 99.76% Phase 2
HY-103712A Samuraciclib hydrochloride Inhibitor 99.98% Phase 2
HY-13914 Roniciclib Inhibitor 98.03% Phase 2
HY-112272A Lerociclib dihydrochloride Inhibitor 98.11% Phase 2
HY-103712B Samuraciclib hydrochloride hydrate Inhibitor 99.08% Phase 2
HY-16559 Riviciclib hydrochloride 99.01% Phase 2
HY-50943 AT7519 Hydrochloride Inhibitor 99.42% Phase 2
HY-112272 Lerociclib Inhibitor / Phase 2
HY-16559A Riviciclib Inhibitor / Phase 2
HY-138293 SY-5609 Inhibitor 99.66% Phase 1
HY-10008 SNS-032 Inhibitor 99.51% Phase 1
HY-137478A KB-0742 dihydrochloride Inhibitor 99.24% Phase 1
HY-10012 AZD-5438 Inhibitor 99.85% Phase 1
HY-12871B Atuveciclib Inhibitor 99.80% Phase 1
HY-11001 PHA-793887 Inhibitor 99.25% Phase 1
HY-15504 RGB-286638 Inhibitor 99.84% Phase 1
HY-12422 Voruciclib Inhibitor 99.77% Phase 1
HY-15504A RGB-286638 free base Inhibitor 98.07% Phase 1
HY-12422A Voruciclib hydrochloride Inhibitor 99.23% Phase 1
HY-50940A AT7519 TFA Inhibitor 98.53% Phase 1
Pre-clinical Phase
生物活性分子 (88)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-103618 THZ531 Inhibitor 99.86% 否
HY-103248 Toyocamycin Inhibitor 99.90% 否
HY-12214A NVP-2 Inhibitor 99.60% 否
HY-103019 Enitociclib Inhibitor 99.66% 否
HY-130665 TL12-186 Inhibitor 99.63% 否
HY-111388A SEL120-34A monohydrochloride Inhibitor 98.69% 否
HY-101257 YKL-5-124 Inhibitor 98.79% 否
HY-130709 PROTAC CDK2/9 Degrader-1 Inhibitor 99.85% 否
HY-11009 CGP60474 Inhibitor 99.23% 否
HY-123954 Casein Kinase inhibitor A51 Inhibitor 98.58% 否
HY-13461A PHA-767491 hydrochloride Inhibitor 98.06% 否
HY-18340 (R)​-​CR8 Inhibitor 99.21% 否
HY-13266A BS-181 hydrochloride Inhibitor 99.80% 否
HY-12445 Asnuciclib Inhibitor 99.76% 否
HY-15878 LDC000067 Inhibitor 98.00% 否
HY-18340A (R)-CR8 trihydrochloride Inhibitor 98.95% 否
HY-X0150 JSH-150 Inhibitor 98.36% 否
HY-103628 PROTAC CDK9 Degrader-1 Inhibitor 98.03% 否
HY-112626 CDK12-IN-2 Inhibitor 99.44% 否
HY-12293 LY2857785 Inhibitor 99.92% 否
HY-16462 CDK9-IN-2 Inhibitor 99.37% 否
HY-117203A CDK12-IN-E9 Inhibitor 99.97% 否
HY-119940 MC180295 Inhibitor 98.89% 否
HY-12280 THZ2 Inhibitor 99.03% 否
HY-144117 GFB-12811 Inhibitor 98.00% 否
HY-101257B YKL-5-124 TFA Inhibitor 99.44% 否
HY-143584 AZ5576 Inhibitor 99.88% 否
HY-13033 CDK-IN-2 Inhibitor 98.97% 否
HY-15241 NVP-LCQ195 Inhibitor 98.91% 否
HY-111388B SEL120-34A hydrochloride Inhibitor 99.98% 否
HY-103019B (-)-Enitociclib Inhibitor 99.81% 否
HY-13231 CDK9-IN-1 Inhibitor 95.76% 否
HY-126251 CDK9-IN-7 Inhibitor 98.05% 否
HY-18944 FIT-039 Inhibitor 99.56% 否
HY-123955 Casein Kinase inhibitor A86 Inhibitor 98.47% 否
HY-103712C Samuraciclib hydrochloride hydrate Inhibitor 99.88% 否
HY-12871 Atuveciclib Racemate Inhibitor 98.48% 否
HY-102039 CDK9-IN-8 Inhibitor 99.65% 否
HY-12843 Bohemine Inhibitor 98.93% 否
HY-103646 CK7 Inhibitor 99.23% 否
HY-139328 CDK12-IN-5 Inhibitor 99.01% 否
HY-153556 GW297361 Inhibitor 98.13% 否
HY-100429 CAN508 Inhibitor 99.59% 否
HY-153260 TP-1287 Inhibitor 95.10% 否
HY-111427 CDK8/19-IN-1 Inhibitor 98.03% 否
HY-130850 CDK9-IN-10 Inhibitor 98.00% 否
HY-124639 CDK9 inhibitor HH1 Inhibitor 97.97% 否
HY-162037 CDDD11-8 Inhibitor 98.74% 否
HY-139980 CDK9-IN-13 Inhibitor 99.22% 否
HY-13266 BS-181 Inhibitor 98.10% 否
HY-100950 ABC1183 Inhibitor 99.19% 否
HY-111388 SEL120-34A Inhibitor / 否
HY-14372 BS-194 Inhibitor 99.36% 否
HY-13461 PHA-767491 Inhibitor / 否
HY-151436 ZLMT-12 Inhibitor / 否
HY-110368 BS-181 dihydrochloride Inhibitor / 否
HY-131063 CDK6/9-IN-1 Inhibitor / 否
HY-130981 FN-1501-propionic acid / 否
HY-130001 CDK9-IN-9 Inhibitor / 否
HY-103712 Samuraciclib Inhibitor / 否
HY-149963 PROTAC CDK9 degrader-6 Inhibitor / 否
HY-143585 CDK9-IN-14 Inhibitor / 否
HY-156795 PROTAC CDK9/CycT1 Degrader-2 Inhibitor / 否
HY-145408 CDK7/9-IN-1 Inhibitor / 否
HY-149962 PROTAC CDK9 degrader-5 Inhibitor / 否
HY-150641 CDK-IN-9 Inhibitor / 否
HY-153426 CDK9-IN-23 Inhibitor / 否
HY-156083 CDK9-IN-28 Inhibitor / 否
HY-151898 CDK4/6-IN-14 Inhibitor / 否
HY-137478 KB-0742 Inhibitor / 否
HY-112811 PROTAC CDK9 degrader-2 Inhibitor / 否
HY-130852 CDK9-IN-11 Inhibitor / 否
HY-151878 CDK7-IN-20 Inhibitor / 否
HY-115714 CDK9-IN-12 Inhibitor / 否
HY-157980 CDK9-IN-32 Inhibitor / 否
HY-139327 CDK12-IN-4 Inhibitor / 否
HY-161463 CDK2-IN-28 Inhibitor / 否
HY-155787 SHR5428 Inhibitor / 否
HY-149870 PROTAC CDK9 degrader-8 Inhibitor / 否
HY-139329 CDK12-IN-6 Inhibitor / 否
HY-150573 CDK2-IN-12 Inhibitor / 否
HY-155153 CDK9-IN-24 Inhibitor / 否
HY-147771 ZLWT-37 Inhibitor / 否
HY-161379 CLZX-205 Inhibitor / 否
HY-151984 CDK9-IN-22 Inhibitor / 否
HY-150562 CDK9-IN-19 Inhibitor / 否
HY-142696 CDK6/PIM1-IN-1 Inhibitor / 否
HY-111356 IIIM-290 Inhibitor / 否

直系同源

种属 基因名 来源 基因 ID
Homo sapiens Cdk9 NCBI NCBI:1025
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z